Investor Overview
| Vical Inc (NASDAQ: VICL) | 3:59 PM ET on Feb 8, 2010 | |||
|---|---|---|---|---|
| Last Price | Change | Open | Day High | 52-Week High |
2.99 |
0.14 
(4.912%) |
2.86 | 3.06 | 5.51 |
| Volume | Previous Close | Day Low | 52-Week Low | |
| 334,600 | 2.85 | 2.84 | 1.38 | |
Recent Releases
Feb 4, 2010
Vical Announces News Release and Conference Call Schedule for 2009 Financial Results
Jan 28, 2010
Vical Completes Enrollment in Allovectin-7(r) Phase 3 Trial for Metastatic Melanoma
Events & Presentations
Nov 4, 2009 at 12:00 PM ET
Q3 2009 Vical Inc. Earnings Conference Call
Sep 21, 2009 at 9:30 AM ET
UBS Global Life Sciences Conference